PMID: 7539137May 23, 1995Paper

Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue

Proceedings of the National Academy of Sciences of the United States of America
J ChenS L Schreiber

Abstract

Complexed with its intracellular receptor, FKBP12, the natural product rapamycin inhibits G1 progression of the cell cycle in a variety of mammalian cell lines and in the yeast Saccharomyces cerevisae. Previously, a mammalian protein that directly associates with FKBP12-rapamycin has been identified and its encoding gene has been cloned from both human (designated FRAP) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated RAFT) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43]. The full-length FRAP is a 289-kDa protein containing a putative phosphatidylinositol kinase domain. Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa FKBP12-rapamycin-binding domain within FRAP. This minimal binding domain lies N-terminal to the kinase domain and spans residues 2025-2114. In addition, we have carried out mutagenesis studies to investigate the role of Ser2035, a potential phosphorylation site for protein kinase C within this domain. We now show that the FRAP Ser2035-->Ala mutant displays similar binding affinity when compare...Continue Reading

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·V CalvoB E Bierer
May 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A FrancavillaQ H Zeng
Feb 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G WiederrechtJ J Siekierka
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B E BiererS L Schreiber
Jan 1, 1988·Annual Review of Biophysics and Biophysical Chemistry·W C Johnson
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T A Kunkel
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·M I ChiuV Berlin

❮ Previous
Next ❯

Citations

Jul 12, 2002·The Journal of Gene Medicine·William Y Go, Steffan N Ho
Apr 15, 2006·Current Genetics·Bérangère Pinan-LucarréCorinne Clavé
Jun 7, 2013·Biogerontology·Yuehua WeiYing Cai
Feb 4, 2006·Journal of Biomolecular NMR·Vaclav VeverkaMark D Carr
Aug 8, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Guadalupe AparicioLuis M Antón Aparicio
Aug 15, 2013·Journal of Chemical Biology·Nirmal JethwaBanafshé Larijani
Jan 1, 1996·Life Sciences·F J Dumont, Q Su
Dec 1, 1995·Current Opinion in Cell Biology·M M Chou, J Blenis
Apr 9, 2013·Cellular Signalling·Zhao Zhong ChongHui-Hua Li
May 14, 2003·Transplantation Proceedings·R A Kirken, Y L Wang
Jul 27, 2002·Journal of Biotechnology·Wilfried Weber, Martin Fussenegger
Dec 2, 1999·Molecular and Cellular Endocrinology·N S CutlerM E Cardenas
Aug 27, 2011·ACS Chemical Biology·Joseph H DavisRobert T Sauer
Oct 5, 2011·ACS Chemical Biology·Brenda N Goguen, Barbara Imperiali
Nov 22, 2011·Journal of the American Chemical Society·Sarah A SlavoffAlice Y Ting
Aug 21, 2012·Journal of the American Chemical Society·Oksana M SubachVladislav V Verkhusha
Nov 18, 2009·Journal of the American Chemical Society·Arnaud GautierKai Johnsson
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·R H RubinR E Morris
Sep 1, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Leslie E HuyeCliona M Rooney
Sep 1, 1996·Nature Medicine·V M RiveraM Gilman
Nov 14, 2006·Nature Methods·Ingrid Remy, Stephen W Michnick
Dec 13, 2005·Nature Reviews. Cancer·Andreas G BaderPeter K Vogt
Dec 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Brett LomenickJing Huang
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kyoung Hu LeeWon Do Heo
Jun 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Luciana Madeira da Silva, Stephen M Beverley
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·K A CimprichS L Schreiber
Oct 4, 2011·The Journal of Biological Chemistry·Chien-Hung Chen, Dos D Sarbassov
Feb 2, 2011·Assay and Drug Development Technologies·Deborah MaiAdrie J C Steyn
Mar 20, 2010·Lymphatic Research and Biology·Arnold S Kristof
Oct 21, 2005·Molecular Biology of the Cell·John R SilviusDonato Terrone
Jan 12, 2007·Molecular Biology of the Cell·Xiangyu Liu, X F Steven Zheng
Oct 20, 2006·Molecular Biology of the Cell·Matthew Y Pecot, Vivek Malhotra
May 18, 2000·Journal of the National Cancer Institute·K K Khanna
Mar 11, 2010·Nucleic Acids Research·Raik GrünbergLuis Serrano
Oct 25, 2003·Nucleic Acids Research·Nicolas JullienJean-Paul Herman
Dec 12, 2012·Protein Engineering, Design & Selection : PEDS·Stanley WongKevin Truong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.